Eli Lilly Investing More Into Diabetes
Eli Lilly and Company today announced that it is working closely with Indianapolis on a proposal to invest an additional $180 million in the company’s Indianapolis-based insulin manufacturing operations. The investment is in addition to the company’s November 2012 announcement of a $140 million expansion of the company’s … Read More